BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9252386)

  • 1. The role of the Shc phosphotyrosine interaction/phosphotyrosine binding domain and tyrosine phosphorylation sites in polyoma middle T antigen-mediated cell transformation.
    Blaikie PA; Fournier E; Dilworth SM; Birnbaum D; Borg JP; Margolis B
    J Biol Chem; 1997 Aug; 272(33):20671-7. PubMed ID: 9252386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
    van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
    Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins.
    Salcini AE; McGlade J; Pelicci G; Nicoletti I; Pawson T; Pelicci PG
    Oncogene; 1994 Oct; 9(10):2827-36. PubMed ID: 8084588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites.
    van der Geer P; Wiley S; Gish GD; Lai VK; Stephens R; White MF; Kaplan D; Pawson T
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):963-8. PubMed ID: 8577769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
    Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
    Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shc binding to nerve growth factor receptor is mediated by the phosphotyrosine interaction domain.
    Dikic I; Batzer AG; Blaikie P; Obermeier A; Ullrich A; Schlessinger J; Margolis B
    J Biol Chem; 1995 Jun; 270(25):15125-9. PubMed ID: 7541035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrimination between phosphotyrosine-mediated signaling properties of conventional and neuronal Shc adapter molecules.
    Nakamura T; Komiya M; Gotoh N; Koizumi S; Shibuya M; Mori N
    Oncogene; 2002 Jan; 21(1):22-31. PubMed ID: 11791173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of Shc with Grb2 regulates association of Grb2 with mSOS.
    Ravichandran KS; Lorenz U; Shoelson SE; Burakoff SJ
    Mol Cell Biol; 1995 Feb; 15(2):593-600. PubMed ID: 7529871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An alternative to phosphotyrosine-containing motifs for binding to an SH2 domain.
    Rojas M; Yao S; Donahue JP; Lin YZ
    Biochem Biophys Res Commun; 1997 May; 234(3):675-80. PubMed ID: 9175774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and molecular cloning of SH2- and SH3-containing inositol polyphosphate-5-phosphatase, which is involved in the signaling pathway of granulocyte-macrophage colony-stimulating factor, erythropoietin, and Bcr-Abl.
    Odai H; Sasaki K; Iwamatsu A; Nakamoto T; Ueno H; Yamagata T; Mitani K; Yazaki Y; Hirai H
    Blood; 1997 Apr; 89(8):2745-56. PubMed ID: 9108392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine phosphorylation of shc in response to B cell antigen receptor engagement depends on the SHIP inositol phosphatase.
    Ingham RJ; Okada H; Dang-Lawson M; Dinglasan J; van Der Geer P; Kurosaki T; Gold MR
    J Immunol; 1999 Dec; 163(11):5891-5. PubMed ID: 10570274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc.
    Dilworth SM; Brewster CE; Jones MD; Lanfrancone L; Pelicci G; Pelicci PG
    Nature; 1994 Jan; 367(6458):87-90. PubMed ID: 7509037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shc, Grb2, Sos1, and a 150-kilodalton tyrosine-phosphorylated protein form complexes with Fms in hematopoietic cells.
    Lioubin MN; Myles GM; Carlberg K; Bowtell D; Rohrschneider LR
    Mol Cell Biol; 1994 Sep; 14(9):5682-91. PubMed ID: 7520523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ShcA and Grb2 mediate polyoma middle T antigen-induced endothelial transformation and Gab1 tyrosine phosphorylation.
    Ong SH; Dilworth S; Hauck-Schmalenberger I; Pawson T; Kiefer F
    EMBO J; 2001 Nov; 20(22):6327-36. PubMed ID: 11707404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions.
    van der Geer P; Wiley S; Gish GD; Pawson T
    Curr Biol; 1996 Nov; 6(11):1435-44. PubMed ID: 8939605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of residues within the SHC phosphotyrosine binding/phosphotyrosine interaction domain crucial for phosphopeptide interaction.
    Yajnik V; Blaikie P; Bork P; Margolis B
    J Biol Chem; 1996 Jan; 271(4):1813-6. PubMed ID: 8567619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis.
    Webster MA; Hutchinson JN; Rauh MJ; Muthuswamy SK; Anton M; Tortorice CG; Cardiff RD; Graham FL; Hassell JA; Muller WJ
    Mol Cell Biol; 1998 Apr; 18(4):2344-59. PubMed ID: 9528804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of Shc/Grb2- and Crk adaptor complexes containing tyrosine phosphorylated Cbl upon stimulation of the B-cell antigen receptor.
    Smit L; van der Horst G; Borst J
    Oncogene; 1996 Jul; 13(2):381-9. PubMed ID: 8710377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen.
    Campbell KS; Ogris E; Burke B; Su W; Auger KR; Druker BJ; Schaffhausen BS; Roberts TM; Pallas DC
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6344-8. PubMed ID: 8022784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shc contains two Grb2 binding sites needed for efficient formation of complexes with SOS in B lymphocytes.
    Harmer SL; DeFranco AL
    Mol Cell Biol; 1997 Jul; 17(7):4087-95. PubMed ID: 9199344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.